hotspot -WSS

hotspot

author：hotspot 2025-10-02 22:26:37 - browse：2889

Cathy McMorris Rodgers -- health policy coverage from STAT — Rep. Cathy McMorris Rodgers (R-Wash.), chair of the House Energy and Commerce Committee. Anna Moneymaker/Getty Images

WASHINGTON — House Republicans have drafted drug-shortage legislation that differs significantly from the approach Democrats propose to stem shortages of chemotherapies and other critical medicines that hospitals typically use.

Republicans on the House Energy and Commerce Committee are focused on what they say are the underlying economic reasons for shortages. Hospitals band together to negotiate drug prices, and makers of generic injectables say those group purchasing organizations can drive prices down so low that they stop making certain drugs or can’t afford to maintain manufacturing facilities, which then leads to manufacturing interruptions.

Rep. Frank Pallone (D-N.J.), the ranking Democrat on Energy and Commerce, called some of the Republican proposals “handouts” to drug companies and said they don’t fix the problem. Democrats also have been critical of Republicans’ choice to separate the drug shortage policies from a must-pass pandemic-preparedness bill — they’d rather combine the two efforts to increase its chances of success.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Surgery pushed Ben Carson to fame

WSS

Illinois Supreme Court finds assault weapons ban constitutional

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Novo Nordisk touts Wegovy study, but still struggling with supply

After Optum profits sink, UnitedHealth makes changes

Biogen’s boardroom scandal saddles CEO with first crisis

Texas Medical Board asked to define abortion emergency exception

leisure time

hotspot

focus

Sports medicine is finally prioritizing gender equality

Devoted Health’s losses in Medicare Advantage persist

Supreme Court strikes down use of affirmative action

BMS, looking to build heart drug business, turns to AI for diagnosis

Cancer drug shortages should be causing more outrage

Surge in Apellis stock fueled by confidence in safety of its eye drug

Tori Bowie and the unacceptable rates of Black maternal death

Medicare Advantage plans can’t deny care with AI, CMS warns

Trump demands the U.S. pay no more for drugs than other countries … again

Medicare Advantage plans can’t deny care with AI, CMS warns

leisure time

Illumina slashes 2023 revenue projections yet again

Novo Nordisk touts Wegovy study, but still struggling with supply

Bird flu researchers hone in on Finland’s mink farms

AstraZeneca stays mum on Medicare drug pricing negotiations

Treatments for cramps don't cut it. Why aren't there better options?

Be careful with at

hotspot

leisure time

hotspot

focus